Literature DB >> 1117495

Colonic urinary diversion: 10 years of experience.

P Morales, M Golimbu.   

Abstract

Experience with 46 colon urinary conduits is summarized. The transverse colon was used in 39 patients and the sigmoid in 7. Initially, we considered widened uretercolic anastomosis with free reflux desirable but later, upon realizing the dangers of reflux, antireflux procedures were incorporated into the operation. Among the advantages of the colon conduit are minimal stomal stenosis, little residuum, less electrolyte disturbance and availability for high and low diversions.

Entities:  

Mesh:

Year:  1975        PMID: 1117495     DOI: 10.1016/s0022-5347(17)59468-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Surgical complications of urinary diversion.

Authors:  Scott B Farnham; Michael S Cookson
Journal:  World J Urol       Date:  2004-08-13       Impact factor: 4.226

2.  [Urinary diversion and colon: transverse conduit and transverse pouch].

Authors:  S A Ahyai; K Sayedahmed; O Engel; F Chun; R Dahlem; M Fisch
Journal:  Urologe A       Date:  2012-07       Impact factor: 0.639

3.  Urology: experience with the transverse colon conduit for supravesical urinary tract diversion.

Authors:  J D Schmidt; H J Buchsbaum; E C Jacobo
Journal:  West J Med       Date:  1977-01

4.  Urinary diversion in children and adolescents with neurogenic bladder: the Mainz experience. Part III: Colonic conduit.

Authors:  Raimund Stein; Christoph Wiesner; Rolf Beetz; Manfred Schwarz; Joachim W Thüroff
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

Review 5.  Treatment of upper urinary lithiasis in patients who have undergone urinary diversion.

Authors:  Gina M Badalato; Janice A Santos Cortes; Mantu Gupta
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

6.  Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation.

Authors:  Sam S Chang; Gregory L Alberts; Joseph A Smith; Michael S Cookson
Journal:  World J Urol       Date:  2004-09-21       Impact factor: 4.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.